Thermo Fisher to report October 21 as analysts expect revenue near $11.9 billion

what happened

Thermo Fisher Scientific is scheduled to report results on October 21 for the quarter ended September 30, 2026, according to Earnings Preview, which cites LSEG data. The mean forecast of 21 analysts points to a 7.4% rise in revenue, to $11.946 billion from $11.12 billion a year earlier.

On earnings, the consensus stands at $6.40 per share, inside the company's July 23 guidance range of $6.38 to $6.43. Of the analysts covering the stock, 27 rate it buy or strong buy, 4 hold, and none sell. The median 12-month price target is $705, about 2.2% above the last close of $690. In the previous quarter, ended June 30, 2026, earnings came in at $6.03 against an expected $5.71.

why it matters

Expectations for revenue and profit at large healthcare and life sciences companies shape sentiment across the sector and the indices that hold the stock. The consensus has barely moved in three months, so the report will test whether growth is holding up. A strong quarter or a guidance revision could reset the valuation, and the gap between the median target and the current price keeps investor attention on the shares.

market impact

Thermo Fisher shares and life sciences sector: results and outlook set sentiment across the group

tags

instruments